{"id":289383,"date":"2026-10-06T11:40:25","date_gmt":"2026-10-06T06:10:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=289383"},"modified":"2026-10-06T11:40:25","modified_gmt":"2026-10-06T06:10:25","slug":"cdmo-stocks-strong-roadmap","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/cdmo-stocks-strong-roadmap\/","title":{"rendered":"3 CDMO Stocks With a Strong Future Roadmap: Divi’s Laboratories, Laurus Labs and Neuland Laboratories"},"content":{"rendered":"

Divi’s Labs Rs 9,196.00, P\/E 83.62. Laurus Labs Rs 1,971.40, P\/E 97.32. Neuland Laboratories Rs 21,875.00, P\/E 56.34. Closing prices of 5 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

CDMO stocks with the clearest long-term roadmaps today include Divi’s Laboratories in generic APIs and custom synthesis for global pharma companies, Laurus Labs in APIs, formulations and a growing CDMO business and Neuland Laboratories in complex generic APIs and custom manufacturing. FY26 revenue growth was 14.0% at Divi’s Labs, 22.0% at Laurus Labs and 37.1% at Neuland Laboratories. P\/E stands at 83.62 for Divi’s Labs (industry 37.53), 97.32 for Laurus Labs (industry 37.53) and 56.34 for Neuland Laboratories (industry 37.53). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

CDMO stocks give investors exposure to global drug makers outsourcing the making of active ingredients to India. Results depend on customer orders, capacity and margins, which is why client relationships and quality records matter as much as headline growth.<\/p>\n

This list covers three API and CDMO stocks: Divi’s Laboratories for generic APIs and custom synthesis for global pharma companies, Laurus Labs for APIs, formulations and a growing CDMO business and Neuland Laboratories for complex generic APIs and custom manufacturing. Every figure comes from the latest reported financials and the 5 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n